Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma

American Journal of Pathology

Volumn 157, Issue 1, 2000, Pages 83-92

  Heinmöller, Ernst ^a,c   Dietmaier, Wolfgang ^a   Zirngibl, Hubert ^b   Heinmöller, Petra ^a,c   Scaringe, William ^c   Jauch, Karl Walter ^a   Hofstädter, Ferdinand ^a   Rüschoff, Josef ^d  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b University Hospital Witten Herdecke   (Germany)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d KLINIKUM KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; PROTEIN P16; PROTEIN P53;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; GENE DELETION; GENE INACTIVATION; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS CARCINOMA; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033871565     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64520-8     Document Type: Article

References (54)

1. Cancer statistics
2. Pancreatic carcinoma
3. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
4. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
5. Tumor-suppressive pathways in pancreatic carcinoma
6. Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations
7. A pancreatic cancer-specific expression profile
8. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization
9. Ki-ras oncogene activation in preinvasive pancreatic cancer
10. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
11. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers
12. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas
13. Detection of p53 overexpression in routinely paraffin embedded tissue of human carcinomas using a novel target unmasking fluid
14. Overexpression of p53 protein in adenocarcinoma of the pancreas
15. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas
16. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
17. Inactivation of the p16(INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
18. Multiple mutation analyses in single tumor cells enabled by improved whole genome amplification
19. Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression
20. Poorly differentiated colonic adenocarcinoma, medullary type
21. Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening method
22. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
23. A network algorithm for performing Fisher's exact test in r x c contingency tables
24. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
25. Homozygous deletions map at 18q21.1 in pancreatic cancer
26. A genetic model for colorectal carcinogenesis
27. Clonal genetic alterations in the lungs of current and former smokers
28. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci
29. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
30. Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty-four karyotypically unrelated clones
31. Allelotype of pancreatic adenocarcinoma using xenograft enrichment
32. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice
33. Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft
34. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts
35. Establishment and long-term xenografting of human pancreatic carcinomas in immunosuppressed mice: Changes and stability in morphology DNA ploidy and proliferation activity
36. Epidermal growth factor receptor somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study
37. Whole genome amplification from a single cell: Implications for genetic analysis
38. Genotypic analysis of multiple loci in somatic cells by whole genome amplification
39. Genetic analysis of multiple loci in microsamples of fixed paraffin-embedded tissue
40. Frequent mutations of CDKN1 in primary pancreatic adenocarcinomas
41. Deletion and mutation analyses of the p16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas
42. Precise microdissection of human prostate cancers reveals genotypic heterogeneity
43. Comparative analysis of mutations of the p53 and K-ras genes in pancreatic cancer
44. K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions
45. Frequent Ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation
46. The quest for preneoplastic lesions in the pancreas
47. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
48. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas
49. Genetic alterations in chronic pancreatitis: Evidence for early occurrence of p53 but not K-ras mutations
50. 1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells
51. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus
52. Pancreatitis and the risk of pancreatic cancer
53. Overexpression of p53 protein during pancreatitis